Vyvanse® (lisdexamfetamine dimesylate) chewable tablet will be publically reimbursed in Ontario for ADHD treatment from March 31, 2020 for individuals (6 years and older) who require 12-hour continuous coverage due to academic and/or psychosocial needs, under these circumstances:
Vyvanse® chewable tablets are administered once daily in the morning and are available in six doses: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg and 60 mg.
As a woman nearing 60yrs, a young senior living wi... Read More
When I first got diagnosed with ADHD just over two... Read More
I always grew up feeling like I never quite belong... Read More
From the tender age of 7, I felt like an outsider... Read More
Hello CADDAC Community, I’m Brenda Logan, a counse... Read More